Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis, Polymyositis, Necrotizing Autoimmune Myopathy, Others), By Treatment (Corticosteroids, Immunosuppressants, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2032

Last Updated: March 17, 2025 | Format: PDF | Report ID: FBI100198

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2015-2026
Base Year	2018
Forecast Period	2019-2026
Historical Period	2015-2017
Unit	Value (USD million)
Segmentation	By Disease Type Dermatomyositis (DM) Polymyositis (PM) Inclusion Body Myositis (IBM) Necrotizing Autoimmune Myopathy (NAM) Others
	By Treatment Corticosteroids Immunosuppressants Intravenous Immunoglobulins Others
	By Route of Administration Oral Intravenous Others
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Others
	By Geography North America (U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)